Centessa Pharmaceuticals plc - CNTA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Pentwater Capital Management LP | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Matthew Halbower | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | INDEX VENTURES LIFE VI (JERSEY) L.P. | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Yucca (Jersey) SLP | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Index Venture Life Associates VI Ltd | 0.0% | 0 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 0.0% | 0 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 0.0% | 0 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Growth I LP | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Growth Co-Invest I LP | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Growth I GP Limited | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Ventures I LP | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Co-Invest I LP | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Ventures I GP Limited | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Secondary I LP | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Secondary Co-Invest I LP | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Secondary I GP Limited | 0.0% | 0 | View |
| Aug 04, 2026 | SCHEDULE 13G/A | Medicxi Ventures Management (Jersey) Limited | 0.0% | 0 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | FMR LLC | 0.0% | 1,800 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 0.0% | 1,800 | View |
| Jun 26, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Jun 24, 2026 | SCHEDULE 13D | — | — | — | View |
| May 15, 2026 | SCHEDULE 13G | Pentwater Capital Management LP | 5.3% | 8,170,000 | View |
| May 15, 2026 | SCHEDULE 13G | Matthew Halbower | 5.3% | 8,170,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Avoro Capital Advisors LLC | 7.39% | 11,430,455 | View |
| May 15, 2026 | SCHEDULE 13G/A | Behzad Aghazadeh | 7.39% | 11,430,455 | View |
| May 13, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.77% | 8,925,010 | View |
| May 13, 2026 | SCHEDULE 13G/A | Robert Atchinson | 5.77% | 8,925,010 | View |
| May 13, 2026 | SCHEDULE 13G/A | Phillip Gross | 5.77% | 8,925,010 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 7.5% | 6,783,047 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 7.5% | 6,783,047 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.